Details for New Drug Application (NDA): 022087
✉ Email this page to a colleague
NDA 022087 describes VECTICAL, which is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. Additional details are available on the VECTICAL profile page.
The generic ingredient in VECTICAL is calcitriol. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
The generic ingredient in VECTICAL is calcitriol. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
Summary for 022087
| Tradename: | VECTICAL |
| Applicant: | Galderma Labs Lp |
| Ingredient: | calcitriol |
| Patents: | 0 |
Suppliers and Packaging for NDA: 022087
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VECTICAL | calcitriol | OINTMENT;TOPICAL | 022087 | NDA | Galderma Laboratories, L.P. | 0299-2012 | 0299-2012-05 | 5 g in 1 TUBE (0299-2012-05) |
| VECTICAL | calcitriol | OINTMENT;TOPICAL | 022087 | NDA | Galderma Laboratories, L.P. | 0299-2012 | 0299-2012-10 | 1 TUBE in 1 CARTON (0299-2012-10) / 100 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 3MCG/GM | ||||
| Approval Date: | Jan 23, 2009 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
